These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 31523926)

  • 1. Design, Synthesis, Molecular Docking, and Cholinesterase Inhibitory Potential of Phthalimide-Dithiocarbamate Hybrids as New Agents for Treatment of Alzheimer's Disease.
    Asadi M; Ebrahimi M; Mohammadi-Khanaposhtani M; Azizian H; Sepehri S; Nadri H; Biglar M; Amanlou M; Larijani B; Mirzazadeh R; Edraki N; Mahdavi M
    Chem Biodivers; 2019 Nov; 16(11):e1900370. PubMed ID: 31523926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics and molecular docking of dihydroxanthyletin-type coumarins from Angelica decursiva that inhibit cholinesterase and BACE1.
    Ali MY; Seong SH; Jung HA; Jannat S; Choi JS
    Arch Pharm Res; 2018 Jul; 41(7):753-764. PubMed ID: 30047040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel chromanone-dithiocarbamate hybrids as multifunctional AChE inhibitors with β-amyloid anti-aggregation properties for the treatment of Alzheimer's disease.
    Jiang N; Ding J; Liu J; Sun X; Zhang Z; Mo Z; Li X; Yin H; Tang W; Xie SS
    Bioorg Chem; 2019 Aug; 89():103027. PubMed ID: 31176237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory activities of major anthraquinones and other constituents from Cassia obtusifolia against β-secretase and cholinesterases.
    Jung HA; Ali MY; Jung HJ; Jeong HO; Chung HY; Choi JS
    J Ethnopharmacol; 2016 Sep; 191():152-160. PubMed ID: 27321278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BACE1 molecular docking and anti-Alzheimer's disease activities of ginsenosides.
    Choi RJ; Roy A; Jung HJ; Ali MY; Min BS; Park CH; Yokozawa T; Fan TP; Choi JS; Jung HA
    J Ethnopharmacol; 2016 Aug; 190():219-30. PubMed ID: 27275774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, biological evaluation, and molecular dynamics of novel cholinesterase inhibitors as anti-Alzheimer's agents.
    Shamsimeymandi R; Pourshojaei Y; Eskandari K; Mohammadi-Khanaposhtani M; Abiri A; Khodadadi A; Langarizadeh A; Sharififar F; Amirheidari B; Akbarzadeh T; Lotfian H; Foroumadi A; Asadipour A
    Arch Pharm (Weinheim); 2019 Jul; 352(7):e1800352. PubMed ID: 31136018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, Synthesis, and Cholinesterase Inhibition Assay of Coumarin-3-carboxamide-N-morpholine Hybrids as New Anti-Alzheimer Agents.
    Tehrani MB; Rezaei Z; Asadi M; Behnammanesh H; Nadri H; Afsharirad F; Moradi A; Larijani B; Mohammadi-Khanaposhtani M; Mahdavi M
    Chem Biodivers; 2019 Jul; 16(7):e1900144. PubMed ID: 31155827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and synthesis of phenoxy methyl-oxadiazole compounds against Alzheimer's disease.
    Evren AE; Nuha D; Özkan BNS; Kahraman Ç; Gönülalan EM; Yurttaş L
    Arch Pharm (Weinheim); 2024 Aug; 357(8):e2400115. PubMed ID: 38657203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sarsasapogenin: A steroidal saponin from Asparagus racemosus as multi target directed ligand in Alzheimer's disease.
    Kashyap P; Muthusamy K; Niranjan M; Trikha S; Kumar S
    Steroids; 2020 Jan; 153():108529. PubMed ID: 31672628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and biological evaluation of new phthalimide and saccharin derivatives with alicyclic amines targeting cholinesterases, beta-secretase and amyloid beta aggregation.
    Panek D; Więckowska A; Wichur T; Bajda M; Godyń J; Jończyk J; Mika K; Janockova J; Soukup O; Knez D; Korabecny J; Gobec S; Malawska B
    Eur J Med Chem; 2017 Jan; 125():676-695. PubMed ID: 27721153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, biological evaluation and molecular modeling studies of methyl indole-isoxazole carbohydrazide derivatives as multi-target anti-Alzheimer's agents.
    Iraji A; Nikfar P; Nazari Montazer M; Karimi M; Edraki N; Saeedi M; Mirfazli SS
    Sci Rep; 2024 Sep; 14(1):21115. PubMed ID: 39256495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phthalimide-Derived N-Benzylpyridinium Halides Targeting Cholinesterases: Synthesis and Bioactivity of New Potential Anti-Alzheimer's Disease Agents.
    Saeedi M; Golipoor M; Mahdavi M; Moradi A; Nadri H; Emami S; Foroumadi A; Shafiee A
    Arch Pharm (Weinheim); 2016 Apr; 349(4):293-301. PubMed ID: 26898241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, and biological evaluation of some 2-(3-oxo-5,6-diphenyl-1,2,4-triazin-2(3H)-yl)-N-phenylacetamide hybrids as MTDLs for Alzheimer's disease therapy.
    Waiker DK; Verma A; Gajendra TA; Namrata ; Roy A; Kumar P; Trigun SK; Srikrishna S; Krishnamurthy S; Davisson VJ; Shrivastava SK
    Eur J Med Chem; 2024 May; 271():116409. PubMed ID: 38663285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel tetrahydrocarbazole benzyl pyridine hybrids as potent and selective butryl cholinesterase inhibitors with neuroprotective and β-secretase inhibition activities.
    Ghobadian R; Mahdavi M; Nadri H; Moradi A; Edraki N; Akbarzadeh T; Sharifzadeh M; Bukhari SNA; Amini M
    Eur J Med Chem; 2018 Jul; 155():49-60. PubMed ID: 29857276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of multi-target-directed ligands (MTDLs) with butyrylcholinesterase (BuChE) and indoleamine 2,3-dioxygenase 1 (IDO1) inhibition: The design, synthesis of miconazole analogues targeting Alzheimer's disease.
    Lu X; He SY; Li Q; Yang H; Jiang X; Lin H; Chen Y; Qu W; Feng F; Bian Y; Zhou Y; Sun H
    Bioorg Med Chem; 2018 May; 26(8):1665-1674. PubMed ID: 29475581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational design, synthesis and biological screening of triazine-triazolopyrimidine hybrids as multitarget anti-Alzheimer agents.
    Jameel E; Meena P; Maqbool M; Kumar J; Ahmed W; Mumtazuddin S; Tiwari M; Hoda N; Jayaram B
    Eur J Med Chem; 2017 Aug; 136():36-51. PubMed ID: 28478343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multipotent AChE and BACE-1 inhibitors for the treatment of Alzheimer's disease: Design, synthesis and bio-analysis of 7-amino-1,4-dihydro-2H-isoquilin-3-one derivates.
    Zhao XJ; Gong DM; Jiang YR; Guo D; Zhu Y; Deng YC
    Eur J Med Chem; 2017 Sep; 138():738-747. PubMed ID: 28728106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Search for new multi-target compounds against Alzheimer's disease among histamine H
    Bajda M; Łażewska D; Godyń J; Zaręba P; Kuder K; Hagenow S; Łątka K; Stawarska E; Stark H; Kieć-Kononowicz K; Malawska B
    Eur J Med Chem; 2020 Jan; 185():111785. PubMed ID: 31669851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, pharmacology and molecular docking on multifunctional tacrine-ferulic acid hybrids as cholinesterase inhibitors against Alzheimer's disease.
    Zhu J; Yang H; Chen Y; Lin H; Li Q; Mo J; Bian Y; Pei Y; Sun H
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):496-506. PubMed ID: 29405075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics and molecular docking studies of loganin, morroniside and 7-O-galloyl-D-sedoheptulose derived from Corni fructus as cholinesterase and β-secretase 1 inhibitors.
    Bhakta HK; Park CH; Yokozawa T; Min BS; Jung HA; Choi JS
    Arch Pharm Res; 2016 Jun; 39(6):794-805. PubMed ID: 27106028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.